Cargando…
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685350/ https://www.ncbi.nlm.nih.gov/pubmed/33236017 http://dx.doi.org/10.1101/2020.11.18.388868 |
_version_ | 1783613166773600256 |
---|---|
author | Mehalko, Jennifer Drew, Matthew Snead, Kelly Denson, John-Paul Wall, Vanessa Taylor, Troy Sadtler, Kaitlyn Messing, Simon Gillette, William Esposito, Dominic |
author_facet | Mehalko, Jennifer Drew, Matthew Snead, Kelly Denson, John-Paul Wall, Vanessa Taylor, Troy Sadtler, Kaitlyn Messing, Simon Gillette, William Esposito, Dominic |
author_sort | Mehalko, Jennifer |
collection | PubMed |
description | The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-7685350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-76853502020-11-25 Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays Mehalko, Jennifer Drew, Matthew Snead, Kelly Denson, John-Paul Wall, Vanessa Taylor, Troy Sadtler, Kaitlyn Messing, Simon Gillette, William Esposito, Dominic bioRxiv Article The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attributed to particular forms of the protein. To improve the yield of these high-sensitivity forms of RBD and support the increased demand for this antigen in serology assays, we investigated several protein expression variables including DNA elements such as promoters and signal peptides, cell culture expression parameters, and purification processes. Through this investigation, we developed a simplified and robust purification strategy that consistently resulted in high levels of the high-sensitivity form of RBD and demonstrated that a carboxyterminal tag is responsible for the increased sensitivity in the ELISA. These improved reagents and processes produce high-quality proteins which are functional in serology assays and can be used to investigate seropositivity to SARS-CoV-2 infection. Cold Spring Harbor Laboratory 2020-11-18 /pmc/articles/PMC7685350/ /pubmed/33236017 http://dx.doi.org/10.1101/2020.11.18.388868 Text en https://creativecommons.org/publicdomain/zero/1.0/This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license (https://creativecommons.org/publicdomain/zero/1.0/) . |
spellingShingle | Article Mehalko, Jennifer Drew, Matthew Snead, Kelly Denson, John-Paul Wall, Vanessa Taylor, Troy Sadtler, Kaitlyn Messing, Simon Gillette, William Esposito, Dominic Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays |
title | Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays |
title_full | Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays |
title_fullStr | Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays |
title_full_unstemmed | Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays |
title_short | Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays |
title_sort | improved production of sars-cov-2 spike receptor-binding domain (rbd) for serology assays |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685350/ https://www.ncbi.nlm.nih.gov/pubmed/33236017 http://dx.doi.org/10.1101/2020.11.18.388868 |
work_keys_str_mv | AT mehalkojennifer improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT drewmatthew improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT sneadkelly improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT densonjohnpaul improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT wallvanessa improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT taylortroy improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT sadtlerkaitlyn improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT messingsimon improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT gillettewilliam improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays AT espositodominic improvedproductionofsarscov2spikereceptorbindingdomainrbdforserologyassays |